• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Novo Nordisk A/S B (OP: NONOF )

    111.54 +2.54 (+2.33%)
    Streaming Delayed Price Updated: 3:50 PM EDT, Nov 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Novo Nordisk A/S B

    Novo Nordisk's Wegovy Demonstrates Greater Weight Loss In Women With Heart Condition
    The greater weight loss in women did not result in significantly better improvements in heart failure symptoms. 
    Via Benzinga
    Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss
    As per the official press release, the 16-week trial aimed to evaluate the safety, tolerability, and clinical effects of the drug called petrelintide. 
    Via Benzinga
    The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
    Dividend stocks have a record of stability and growth. Read here about three picks that are thriving and hiking dividends amid uncertainty. 
    Via InvestorPlace
    Novo Nordisk's Wegovy Delivers: Long-Term Study Shows Sustained Weight Loss As Drugmaker Tries To Woo Insurers And Governments
    The data could potentially bolster Novo's case for Wegovy as it attempts to convince insurers and governments to cover the cost of the drug. 
    Via Benzinga
    7 Mutual Funds That Will Outperform in Any Market
    While we’d all love to think we’re market geniuses, we could use the active management of outperforming mutual funds. 
    Via InvestorPlace
    Did Ozempic Play A Role In A Man's Suicide? Family Seeks Warning Label
    Via Benzinga
    Emmanuel Macron To Unveil Novo Nordisk Record $2.3B Investment In France's Health Sector
    This initiative has been touted as the biggest investment in the health sector ever made during Macron's tenure. 
    Via Benzinga
    Experts Weigh In On Ozempic's Evolving Side Effects And How To Handle Them
    Via Benzinga
    Diabetes Drug Ozempic May Hold Key to Breaking Addictions: The Guardian
    Via Benzinga
    Icannex Taps Ex Pfizer, FDA & Regulatory Affairs Expert
    Incannex Healthcare Limited (NASDAQ: IXHL) (ASX:IHL) appointed pharmaceutical executive Robert B. Clark to the board of directors. 
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.